artificial intelligence; lung diseases; precision medicine; radiomics; Medicine (miscellaneous)
Abstract :
[en] Artificial intelligence (AI) has increasingly been serving the field of radiology over the last 50 years. As modern medicine is evolving towards precision medicine, offering personalized patient care and treatment, the requirement for robust imaging biomarkers has gradually increased. Radiomics, a specific method generating high-throughput extraction of a tremendous amount of quantitative imaging data using data-characterization algorithms, has shown great potential in individuating imaging biomarkers. Radiomic analysis can be implemented through the following two methods: hand-crafted radiomic features extraction or deep learning algorithm. Its application in lung diseases can be used in clinical decision support systems, regarding its ability to develop descriptive and predictive models in many respiratory pathologies. The aim of this article is to review the recent literature on the topic, and briefly summarize the interest of radiomics in chest Computed Tomography (CT) and its pertinence in the field of pulmonary diseases, from a clinician's perspective.
Disciplines :
Cardiovascular & respiratory systems Radiology, nuclear medicine & imaging
Author, co-author :
Frix, Anne-Noëlle ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
COUSIN, François ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Refaee, Turkey ; The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 Maastricht, The Netherlands ; Department of Diagnostic Radiology, Faculty of Applied Sciences, Jazan University, Jazan 45142, Saudi Arabia
Bottari, Fabio; Research and Development, Radiomics, 4000 Liège, Belgium
Vaidyanathan, Akshayaa; The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 Maastricht, The Netherlands ; Research and Development, Radiomics, 4000 Liège, Belgium
DESIR, Colin ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Vos, Wim; Research and Development, Radiomics, 4000 Liège, Belgium
Walsh, Sean; Research and Development, Radiomics, 4000 Liège, Belgium
Occhipinti, Mariaelena; Research and Development, Radiomics, 4000 Liège, Belgium
LOVINFOSSE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Leijenaar, Ralph T H; Research and Development, Radiomics, 4000 Liège, Belgium
HUSTINX, Roland ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
MEUNIER, Paul ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
LOUIS, Renaud ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
Lambin, Philippe ; The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 Maastricht, The Netherlands
GUIOT, Julien ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
Lambin, P.; Rios-Velazquez, E.; Leijenaar, R.; Carvalho, S.; van Stiphout, R.G.P.M.; Granton, P.; Zegers, C.M.L.; Gillies, R.; Boellard, R.; Dekker, A.; et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 2012, 48, 441–446. [CrossRef] [PubMed]
Wilson, D.O.; Ryan, A.; Fuhrman, C.; Schuchert, M.; Shapiro, S.; Siegfried, J.M.; Weissfeld, J. Doubling Times and CT Screen– Detected Lung Cancers in the Pittsburgh Lung Screening Study. Am. J. Respir. Crit. Care Med. 2012, 185, 85–89. [CrossRef]
Hasegawa, M.; Sone, S.; Takashima, S.; Li, F.; Yang, Z.G.; Maruyama, Y.; Watanabe, T. Growth rate of small lung cancers detected on mass CT screening. Br. J. Radiol. 2000, 73, 1252–1259. [CrossRef] [PubMed]
Ko, J.P.; Berman, E.J.; Kaur, M.; Babb, J.S.; Bomsztyk, E.; Greenberg, A.K.; Naidich, D.P.; Rusinek, H. Pulmonary Nodules: Growth Rate Assessment in Patients by Using Serial CT and Three-dimensional Volumetry. Radiology 2012, 262, 662–671. [CrossRef] [PubMed]
Nordstrom, R.J. The Quantitative Imaging Network in Precision Medicine. Tomography 2016, 2, 239–241. [CrossRef] [PubMed]
Ather, S.; Kadir, T.; Gleeson, F. Artificial intelligence and radiomics in pulmonary nodule management: Current status and future applications. Clin. Radiol. 2020, 75, 13–19. [CrossRef]
Chen, C.-H.; Chang, C.-K.; Tu, C.-Y.; Liao, W.-C.; Wu, B.-R.; Chou, K.-T.; Chiou, Y.-R.; Yang, S.-N.; Zhang, G.; Huang, T.-C. Radiomic features analysis in computed tomography images of lung nodule classification. PLoS ONE 2018, 13, e0192002. [CrossRef] [PubMed]
Horeweg, N.; van der Aalst, C.M.; Vliegenthart, R.; Zhao, Y.; Xie, X.; Scholten, E.T.; Mali, W.; Thunnissen, E.; Weenink, C.; Groen, H.J.M.; et al. Volumetric computed tomography screening for lung cancer: Three rounds of the NELSON trial. Eur. Respir. J. 2013, 42, 1659–1667. [CrossRef]
de Koning, H.J.; van der Aalst, C.M.; de Jong, P.A.; Scholten, E.T.; Nackaerts, K.; Heuvelmans, M.A.; Lammers, J.-W.J.; Weenink, C.; Yousaf-Khan, U.; Horeweg, N.; et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020, 382, 503–513. [CrossRef]
Ma, J.; Wang, Q.; Ren, Y.; Hu, H.; Zhao, J. Automatic lung nodule classification with radiomics approach. In Medical Imaging 2016: PACS and Imaging Informatics: Next Generation and Innovations; Zhang, J., Cook, T.S., Eds.; International Society for Optics and Photonics: San Diego, CA, USA, 2016; p. 978906. Available online: http://proceedings.spiedigitallibrary.org/proceeding.aspx? doi=10.1117/12.2220768 (accessed on 21 June 2021).
Huang, P.; Park, S.; Yan, R.; Lee, J.; Chu, L.C.; Lin, C.T.; Hussien, A.; Rathmell, J.; Thomas, B.; Chen, C.; et al. Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study. Radiology 2018, 286, 286–295. [CrossRef] [PubMed]
Uthoff, J.; Stephens, M.J.; Newell, J.D.; Hoffman, E.A.; Larson, J.; Koehn, N.; De Stefano, F.A.; Lusk, C.M.; Wenzlaff, A.S.; Watza, D.; et al. Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT. Med. Phys. 2019, 46, 3207–3216. [CrossRef] [PubMed]
Mao, L.; Chen, H.; Liang, M.; Li, K.; Gao, J.; Qin, P.; Ding, X.; Li, X.; Liu, X. Quantitative radiomic model for predicting malignancy of small solid pulmonary nodules detected by low-dose CT screening. Quant. Imaging Med. Surg. 2019, 9, 263–272. [CrossRef] [PubMed]
ACR. Lung CT Screening Reporting & Data System (Lung-RADS). Available online: https://www.acr.org (accessed on 20 April 2021).
Lee, S.H.; Lee, S.M.; Goo, J.M.; Kim, K.-G.; Kim, Y.J.; Park, C.M. Usefulness of Texture Analysis in Differentiating Transient from Persistent Part-solid Nodules(PSNs): A Retrospective Study. PLoS ONE 2014, 9, e85167.
Autrusseau, P.-A.; Labani, A.; De Marini, P.; Leyendecker, P.; Hintzpeter, C.; Ortlieb, A.-C.; Calhoun, M.; Goldberg, I.; Roy, C.; Ohana, M. Radiomics in the evaluation of lung nodules: Intrapatient concordance between full-dose and ultra-low-dose chest computed tomography. Diagn. Interv. Imaging 2021, 102, 233–239. [CrossRef]
Maldonado, F.; Varghese, C.; Rajagopalan, S.; Duan, F.; Balar, A.B.; Lakhani, D.A.; Antic, S.L.; Massion, P.P.; Johnson, T.F.; Karwoski, R.A.; et al. Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. Eur. Respir. J. 2021, 57, 2002485. [CrossRef]
Murphy, A.; Skalski, M.; Gaillard, F. The utilisation of convolutional neural networks in detecting pulmonary nodules: A review. Br. J. Radiol. 2018, 91, 20180028. [CrossRef]
da Silva, G.L.F.; Valente, T.L.A.; Silva, A.C.; de Paiva, A.C.; Gattass, M. Convolutional neural network-based PSO for lung nodule false positive reduction on CT images. Comput. Methods Programs Biomed. 2018, 162, 109–118. [CrossRef]
Li, S.; Xu, P.; Li, B.; Chen, L.; Zhou, Z.; Hao, H.; Duan, Y.; Folkert, M.; Ma, J.; Huang, S.; et al. Predicting lung nodule malignancies by combining deep convolutional neural network and handcrafted features. Phys. Med. Biol. 2019, 64, 175012. [CrossRef]
Mehta, K.; Jain, A.; Mangalagiri, J.; Menon, S.; Nguyen, P.; Chapman, D.R. Lung Nodule Classification Using Biomarkers, Volumetric Radiomics, and 3D CNNs. J. Digit. Imaging 2021. [CrossRef]
Wu, W.; Parmar, C.; Grossmann, P.; Quackenbush, J.; Lambin, P.; Bussink, J.; Mak, R.; Aerts, H.J.W.L. Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology. Front. Oncol. 2016, 6, 71. [CrossRef]
Digumarthy, S.R.; Padole, A.M.; Rastogi, S.; Price, M.; Mooradian, M.J.; Sequist, L.V.; Kalra, M.K. Predicting malignant potential of subsolid nodules: Can radiomics preempt longitudinal follow up CT? Cancer Imaging 2019, 19, 36. [CrossRef]
Radiomics of Lung Nodules: A Multi-Institutional Study of Robustness and Agreement of Quantitative Imaging Features. Tomography 2016, 2, 430–437. [CrossRef] [PubMed]
Balagurunathan, Y.; Gu, Y.; Wang, H.; Kumar, V.; Grove, O.; Hawkins, S.; Kim, J.; Goldgof, D.B.; Hall, L.O.; Gatenby, R.A.; et al. Reproducibility and Prognosis of Quantitative Features Extracted from CT Images. Transl. Oncol. 2014, 7, 72–87. [CrossRef] [PubMed]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [CrossRef]
The National Lung Screening Trial Research Team Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N. Engl. J. Med. 2011, 365, 395–409. [CrossRef] [PubMed]
National Lung Screening Trial Research Team Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 2019, 14, 1732–1742.
Refaee, T.; Wu, G.; Ibrahim, A.; Halilaj, I.; Leijenaar, R.T.H.; Rogers, W.; Gietema, H.A.; Hendriks, L.E.L.; Lambin, P.; Woodruff, H.C. The Emerging Role of Radiomics in COPD and Lung Cancer. Respiration 2020, 99, 99–107. [CrossRef] [PubMed]
Aerts, H.J.W.L.; Velazquez, E.R.; Leijenaar, R.T.H.; Parmar, C.; Grossmann, P.; Carvalho, S.; Cavalho, S.; Bussink, J.; Monshouwer, R.; Haibe-Kains, B.; et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 2014, 5, 4006. [CrossRef]
Maldonado, F.; Boland, J.M.; Raghunath, S.; Aubry, M.C.; Bartholmai, B.J.; Deandrade, M.; Hartman, T.E.; Karwoski, R.A.; Rajagopalan, S.; Sykes, A.-M.; et al. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)—A pilot study. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 2013, 8, 452–460. [CrossRef]
Liu, Y.; Balagurunathan, Y.; Atwater, T.; Antic, S.; Li, Q.; Walker, R.C.; Smith, G.T.; Massion, P.P.; Schabath, M.B.; Gillies, R.J. Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2017, 23, 1442–1449. [CrossRef] [PubMed]
Yu, L.; Tao, G.; Zhu, L.; Wang, G.; Li, Z.; Ye, J.; Chen, Q. Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis. BMC Cancer 2019, 19, 464. [CrossRef] [PubMed]
Zhang, L.; Chen, B.; Liu, X.; Song, J.; Fang, M.; Hu, C.; Dong, D.; Li, W.; Tian, J. Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer. Transl. Oncol. 2018, 11, 94–101. [CrossRef]
Liu, Y.; Kim, J.; Balagurunathan, Y.; Li, Q.; Garcia, A.L.; Stringfield, O.; Ye, Z.; Gillies, R.J. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas. Clin. Lung Cancer 2016, 17, 441–448.e6. [CrossRef]
Rios Velazquez, E.; Parmar, C.; Liu, Y.; Coroller, T.P.; Cruz, G.; Stringfield, O.; Ye, Z.; Makrigiorgos, M.; Fennessy, F.; Mak, R.H.; et al. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. Cancer Res. 2017, 77, 3922–3930. [CrossRef]
Weiss, G.J.; Ganeshan, B.; Miles, K.A.; Campbell, D.H.; Cheung, P.Y.; Frank, S.; Korn, R.L. Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic. PLoS ONE 2014, 9, e100244.
Tang, C.; Hobbs, B.; Amer, A.; Li, X.; Behrens, C.; Canales, J.R.; Cuentas, E.P.; Villalobos, P.; Fried, D.; Chang, J.Y.; et al. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci. Rep. 2018, 8, 1922. [CrossRef] [PubMed]
Wu, G.; Woodruff, H.C.; Shen, J.; Refaee, T.; Sanduleanu, S.; Ibrahim, A.; Leijenaar, R.T.H.; Wang, R.; Xiong, J.; Bian, J.; et al. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study. Radiology 2020, 297, E282. [CrossRef]
Song, J.; Liu, Z.; Zhong, W.; Huang, Y.; Ma, Z.; Dong, D.; Liang, C.; Tian, J. Non-small cell lung cancer: Quantitative phenotypic analysis of CT images as a potential marker of prognosis. Sci. Rep. 2016, 6, 38282. [CrossRef]
He, L.; Huang, Y.; Yan, L.; Zheng, J.; Liang, C.; Liu, Z. China Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer. Chin. J. Cancer Res. 2019, 31, 641–652. [CrossRef] [PubMed]
Hosny, A.; Parmar, C.; Coroller, T.P.; Grossmann, P.; Zeleznik, R.; Kumar, A.; Bussink, J.; Gillies, R.J.; Mak, R.H.; Aerts, H.J.W.L. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. PLOS Med. 2018, 15, e1002711. [CrossRef] [PubMed]
Ferreira Junior, J.R.; Koenigkam-Santos, M.; Cipriano, F.E.G.; Fabro, A.T.; Azevedo-Marques, P.M. de Radiomics-based features for pattern recognition of lung cancer histopathology and metastases. Comput. Methods Programs Biomed. 2018, 159, 23–30. [CrossRef] [PubMed]
Mattonen, S.A.; Palma, D.A.; Johnson, C.; Louie, A.V.; Landis, M.; Rodrigues, G.; Chan, I.; Etemad-Rezai, R.; Yeung, T.P.C.; Senan, S.; et al. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment. Int. J. Radiat. Oncol. 2016, 94, 1121–1128. [CrossRef] [PubMed]
Chetan, M.R.; Gleeson, F.V. Radiomics in predicting treatment response in non-small-cell lung cancer: Current status, challenges and future perspectives. Eur. Radiol. 2021, 31, 1049–1058. [CrossRef]
Bera, K.; Velcheti, V.; Madabhushi, A. Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications. Am. Soc. Clin. Oncol. Educ. Book 2018, 38, 1008–1018. [CrossRef]
Kim, H.; Park, C.M.; Keam, B.; Park, S.J.; Kim, M.; Kim, T.M.; Kim, D.-W.; Heo, D.S.; Goo, J.M. The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors. PLoS ONE 2017, 12, e0187500. [CrossRef]
Limkin, E.J.; Sun, R.; Dercle, L.; Zacharaki, E.I.; Robert, C.; Reuzé, S.; Schernberg, A.; Paragios, N.; Deutsch, E.; Ferté, C. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann. Oncol. 2017, 28, 1191–1206. [CrossRef]
Lafata, K.J.; Zhou, Z.; Liu, J.-G.; Hong, J.; Kelsey, C.R.; Yin, F.-F. An Exploratory Radiomics Approach to Quantifying Pulmonary Function in CT Images. Sci. Rep. 2019, 9, 11509. [CrossRef]
Gevenois, P.A.; de Maertelaer, V.; De Vuyst, P.; Zanen, J.; Yernault, J.C. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am. J. Respir. Crit. Care Med. 1995, 152, 653–657. [CrossRef] [PubMed]
Madani, A.; Zanen, J.; de Maertelaer, V.; Gevenois, P.A. Pulmonary emphysema: Objective quantification at multi-detector row CT–comparison with macroscopic and microscopic morphometry. Radiology 2006, 238, 1036–1043. [CrossRef]
de Jong, P.A.; Müller, N.L.; Paré, P.D.; Coxson, H.O. Computed tomographic imaging of the airways: Relationship to structure and function. Eur. Respir. J. 2005, 26, 140–152. [CrossRef] [PubMed]
Madani, A.; Van Muylem, A.; Gevenois, P.A. Pulmonary Emphysema: Effect of Lung Volume on Objective Quantification at Thin-Section CT. Radiology 2010, 257, 260–268. [CrossRef]
Bankier, A.A.; De Maertelaer, V.; Keyzer, C.; Gevenois, P.A. Pulmonary Emphysema: Subjective Visual Grading versus Objective Quantification with Macroscopic Morphometry and Thin-Section CT Densitometry. Radiology 1999, 211, 851–858. [CrossRef]
Mohamed Hoesein, F.A.A.; de Hoop, B.; Zanen, P.; Gietema, H.; Kruitwagen, C.L.J.J.; van Ginneken, B.; Isgum, I.; Mol, C.; van Klaveren, R.J.; Dijkstra, A.E.; et al. CT-quantified emphysema in male heavy smokers: Association with lung function decline. Thorax 2011, 66, 782–787. [CrossRef]
Pompe, E.; van Rikxoort, E.M.; Schmidt, M.; Rühaak, J.; Estrella, L.G.; Vliegenthart, R.; Oudkerk, M.; de Koning, H.J.; van Ginneken, B.; de Jong, P.A.; et al. Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2015, 191, 1084–1086. [CrossRef]
Hackx, M.; Francotte, D.; Garcia, T.S.; Van Muylem, A.; Walsdorff, M.; Gevenois, P.A. Effect of total lung capacity, gender and height on CT airway measurements. Br. J. Radiol. 2017, 90, 20160898. [CrossRef]
Ginsburg, S.B.; Lynch, D.A.; Bowler, R.P.; Schroeder, J.D. Automated Texture-based Quantification of Centrilobular Nodularity and Centrilobular Emphysema in Chest CT Images. Acad. Radiol. 2012, 19, 1241–1251. [CrossRef]
Martini, K.; Frauenfelder, T. Advances in imaging for lung emphysema. Ann. Transl. Med. 2020, 8, 1467. [CrossRef]
Lynch, D.A.; Austin, J.H.M.; Hogg, J.C.; Grenier, P.A.; Kauczor, H.-U.; Bankier, A.A.; Barr, R.G.; Colby, T.V.; Galvin, J.R.; Gevenois, P.A.; et al. CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. Radiology 2015, 277, 192–205. [CrossRef]
Occhipinti, M.; Paoletti, M.; Bartholmai, B.J.; Rajagopalan, S.; Karwoski, R.A.; Nardi, C.; Inchingolo, R.; Larici, A.R.; Camiciottoli, G.; Lavorini, F.; et al. Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD. Respir. Res. 2019, 20, 101. [CrossRef]
Cho, Y.H.; Seo, J.B.; Lee, S.M.; Kim, N.; Yun, J.; Hwang, J.E.; Lee, J.S.; Oh, Y.-M.; Do Lee, S.; Loh, L.-C.; et al. Radiomics approach for survival prediction in chronic obstructive pulmonary disease. Eur. Radiol. 2021. [CrossRef]
Cho, Y.H.; Lee, S.M.; Seo, J.B.; Kim, N.; Bae, J.P.; Lee, J.S.; Oh, Y.-M.; Do-Lee, S. Quantitative assessment of pulmonary vascular alterations in chronic obstructive lung disease: Associations with pulmonary function test and survival in the KOLD cohort. Eur. J. Radiol. 2018, 108, 276–282. [CrossRef]
Stockley, R.A.; Parr, D.G.; Piitulainen, E.; Stolk, J.; Stoel, B.C.; Dirksen, A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: An integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir. Res. 2010, 11, 136. [CrossRef]
Chandra, D.; Lipson, D.A.; Hoffman, E.A.; Hansen-Flaschen, J.; Sciurba, F.C.; DeCamp, M.M.; Reilly, J.J.; Washko, G.R. Perfusion Scintigraphy and Patient Selection for Lung Volume Reduction Surgery. Am. J. Respir. Crit. Care Med. 2010, 182, 937–946. [CrossRef]
Milanese, G.; Silva, M.; Sverzellati, N. Lung volume reduction of pulmonary emphysema: The radiologist task. Curr. Opin. Pulm. Med. 2016, 22, 179–186. [CrossRef]
Gupta, S.; Hartley, R.; Khan, U.T.; Singapuri, A.; Hargadon, B.; Monteiro, W.; Pavord, I.D.; Sousa, A.R.; Marshall, R.P.; Subrama-nian, D.; et al. Quantitative computed tomography–derived clusters: Redefining airway remodeling in asthmatic patients. J. Allergy Clin. Immunol. 2014, 133, 729–738.e18. [CrossRef]
Tunon-de-Lara, J.-M.; Laurent, F.; Giraud, V.; Perez, T.; Aguilaniu, B.; Meziane, H.; Basset-Merle, A.; Chanez, P. Air trapping in mild and moderate asthma: Effect of inhaled corticosteroids. J. Allergy Clin. Immunol. 2007, 119, 583–590. [CrossRef]
Walsh, S.L.F.; Calandriello, L.; Silva, M.; Sverzellati, N. Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: A case-cohort study. Lancet Respir. Med. 2018, 6, 837–845. [CrossRef]
Schniering, J.; Gabrys, H.; Brunner, M.; Distler, O.; Guckenberger, M.; Bogowicz, M.; Vuong, D.; Karava, K.; Müller, C.; Frauenfelder, T.; et al. Computed-tomography-based radiomics features for staging of interstitial lung disease—Transferability from experimental to human lung fibrosis—A proof-of-concept study. Eur. Respir. Soc. 2019, 54, PA4806. Available online: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.congress-2019.PA4806 (accessed on 23 October 2020).
Stefano, A.; Gioè, M.; Russo, G.; Palmucci, S.; Torrisi, S.E.; Bignardi, S.; Basile, A.; Comelli, A.; Benfante, V.; Sambataro, G.; et al. Performance of Radiomics Features in the Quantification of Idiopathic Pulmonary Fibrosis from HRCT. Diagnostics 2020, 10, 306. [CrossRef] [PubMed]
Martini, K.; Baessler, B.; Bogowicz, M.; Blüthgen, C.; Mannil, M.; Tanadini-Lang, S.; Schniering, J.; Maurer, B.; Frauenfelder, T. Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: Proof of concept. Eur. Radiol. 2021, 31, 1987–1998. [CrossRef]
Ungprasert, P.; Wilton, K.M.; Ernste, F.C.; Kalra, S.; Crowson, C.S.; Rajagopalan, S.; Bartholmai, B.J. Novel Assessment of Interstitial Lung Disease Using the “Computer-Aided Lung Informatics for Pathology Evaluation and Rating” (CALIPER) Software System in Idiopathic Inflammatory Myopathies. Lung 2017, 195, 545–552. [CrossRef] [PubMed]
Kim, H.J.; Brown, M.S.; Chong, D.; Gjertson, D.W.; Lu, P.; Kim, H.J.; Coy, H.; Goldin, J.G. Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months. Acad. Radiol. 2015, 22, 70–80. [CrossRef]
De Giacomi, F.; Raghunath, S.; Karwoski, R.; Bartholmai, B.J.; Moua, T. Short-term Automated Quantification of Radiologic Changes in the Characterization of Idiopathic Pulmonary Fibrosis Versus Nonspecific Interstitial Pneumonia and Prediction of Long-term Survival. J. Thorac. Imaging 2018, 33, 124–131. [CrossRef] [PubMed]
Lee, C.U.; Chong, S.; Choi, H.W.; Choi, J.C. Quantitative image analysis using chest computed tomography in the evaluation of lymph node involvement in pulmonary sarcoidosis and tuberculosis. PLoS ONE 2018, 13, e0207959. [CrossRef] [PubMed]
Jacob, J.; Bartholmai, B.J.; Rajagopalan, S.; Kokosi, M.; Nair, A.; Karwoski, R.; Walsh, S.L.F.; Wells, A.U.; Hansell, D.M. Mortality prediction in idiopathic pulmonary fibrosis: Evaluation of computer-based CT analysis with conventional severity measures. Eur. Respir. J. 2017, 49, 1601011. [CrossRef]
Kim, H.J.; Brown, M.S.; Elashoff, R.; Li, G.; Gjertson, D.W.; Lynch, D.A.; Strollo, D.C.; Kleerup, E.; Chong, D.; Shah, S.K.; et al. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur. Radiol. 2011, 21, 2455–2465. [CrossRef]
Kiely, D.; Lawrie, A.; Doyle, O.; Salvatelli, V.; Daniels, F.; Drage, E.; Jenner, H.; Rigg, J.; Schmitt, C.; Samyshkin, Y.; et al. Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension. Eur. Respir. Soc. 2018, 52, PA3082. Available online: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.congress-2018.PA3082 (accessed on 23 March 2021).
Avendi, M.R.; Kheradvar, A.; Jafarkhani, H. Automatic segmentation of the right ventricle from cardiac MRI using a learning-based approach: Automatic Segmentation Using a Learning-Based Approach. Magn. Reson. Med. 2017, 78, 2439–2448. [CrossRef] [PubMed]
Avendi, M.R.; Kheradvar, A.; Jafarkhani, H. A combined deep-learning and deformable-model approach to fully automatic segmentation of the left ventricle in cardiac MRI. Med. Image Anal. 2016, 30, 108–119. [CrossRef]
Kiely, D.G.; Levin, D.L.; Hassoun, P.M.; Ivy, D.; Jone, P.-N.; Bwika, J.; Kawut, S.M.; Lordan, J.; Lungu, A.; Mazurek, J.A.; et al. Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm. Circ. 2019, 9, 204589401984199. [CrossRef]
Lungu, A.; Swift, A.; Capener, D.; Kiely, D.; Hose, R.; Wild, J. Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis. Eur. Respir. Soc. 2015, 46, PA2109. Available online: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.congress-2015.PA2109 (accessed on 6 December 2020).
Yang, M.; Ren, Y.; She, Y.; Xie, D.; Sun, X.; Shi, J.; Zhao, G.; Chen, C. Imaging phenotype using radiomics to predict dry pleural dissemination in non-small cell lung cancer. Ann. Transl. Med. 2019, 7, 259. [CrossRef]
Yip, S.S.F.; Aerts, H.J.W.L. Applications and limitations of radiomics. Phys. Med. Biol. 2016, 61, R150–R166. [CrossRef]
European Commission. Joint Research Centre. Robustness and Explainability of Artificial Intelligence: From Technical to Policy Solutions. Available online: https://data.europa.eu/doi/10.2760/57493 (accessed on 2 March 2021).
Ibrahim, A.; Primakov, S.; Beuque, M.; Woodruff, H.C.; Halilaj, I.; Wu, G.; Refaee, T.; Granzier, R.; Widaatalla, Y.; Hustinx, R.; et al. Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework. Methods San Diego Calif. 2021, 188, 20–29. [CrossRef]
